Tian'an Pharmaceutical Co., Ltd.
TNPH · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $4,160 | $2,298 | $2,569 | $3,400 |
| - Cash | $0 | $3 | $2 | $107 |
| + Debt | $62 | $57 | $182 | $176 |
| Enterprise Value | $4,222 | $2,352 | $2,748 | $3,468 |
| Revenue | $0 | $143 | $8 | $0 |
| % Growth | -100% | 1,804.5% | – | – |
| Gross Profit | $0 | $68 | $8 | $0 |
| % Margin | – | 47.3% | 100% | – |
| EBITDA | -$1 | -$10 | $208 | -$31 |
| % Margin | – | -7.1% | 2,773.8% | – |
| Net Income | -$1 | -$16 | -$20 | -$31 |
| % Margin | – | -11.2% | -272.7% | – |
| EPS Diluted | 0 | 0 | -0 | -0.001 |
| % Growth | – | 100% | 50% | – |
| Operating Cash Flow | -$3 | -$13 | -$14 | -$26 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$3 | -$13 | -$14 | -$26 |